785 articles
Annovis Bio's buntanetap targets five neurotoxic proteins at once, challenging Alzheimer's single-protein dogma in a pivotal Phase 3 trial.
ROKIT Healthcare reports zero recurrence and sensory recovery in 2-year follow-up using AI-guided regenerative tissue reconstruction.
Scarlet Therapeutics grows universal red blood cells that survive as long as donated ones, opening a path to engineered therapeutic blood.
New research links cognitive speed training to a 25% drop in dementia risk over 20 years, while clinical cases show memory loss can be reversed.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
A quality improvement study found dialysis patients receiving liquid protein supplements had fewer, shorter hospital stays and better nutritional biomarkers.
University of Rochester scientists moved a longevity gene from naked mole rats into mice, boosting lifespan 4.4% and cutting cancer risk.
A stem cell intestine model screened 3,500 compounds and flagged glycyrrhizin from black licorice as a top anti-inflammatory candidate for IBD.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
JNJ-4804 combines two biologics to achieve remission rates far exceeding either drug alone in patients who failed all other IBD treatments.
Rockefeller scientists mapped epigenomic aging across 7M cells in 21 tissues, uncovering coordinated, program-like shifts that may unlock new therapies.
Preclinical data show ACD137 rivals leading anti-NGF antibody Tanezumab for pain relief while also offering anti-inflammatory and joint-protective effects.
